4040 — Nankai Chemical Co Balance Sheet
0.000.00%
- ¥6bn
- ¥10bn
- ¥21bn
- 16
- 91
- 38
- 47
Annual balance sheet for Nankai Chemical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1,107 | 1,281 | 1,301 | 1,710 | 1,703 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5,090 | 5,238 | 4,273 | 3,900 | 3,977 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8,263 | 8,634 | 8,850 | 9,096 | 9,505 |
| Net Property, Plant And Equipment | 6,632 | 6,607 | 7,337 | 8,977 | 10,959 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 16,122 | 16,982 | 18,346 | 20,258 | 22,471 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7,676 | 8,338 | 7,949 | 7,990 | 9,837 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 12,128 | 12,357 | 13,213 | 12,834 | 14,072 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 3,994 | 4,625 | 5,133 | 7,424 | 8,399 |
| Total Liabilities & Shareholders' Equity | 16,122 | 16,982 | 18,346 | 20,258 | 22,471 |
| Total Common Shares Outstanding |